CDSCO Classification Questions Indian Startups Must Ask Before Tooling
A medical device can look ready for moulds and pilot production, yet still be unclear from a regulatory point of view. That is a costly place to be.
For Indian medical device startups and OEM teams, the key manufacturing question is not “Which mould should we cut first?” It is “What exactly is the device intended to do, and how will that affect its classification?”
CDSCO classification affects the evidence you prepare, the product documentation you maintain, the labelling claims you make, and the level of control expected during manufacturing. It can also affect design choices such as materials, tolerances, user interface, packaging, and cleaning method.
This article focuses on the questions to ask before tooling. It is not a licensing roadmap, legal opinion, or promise of regulatory outcome. For official references, manufacturers should review the CDSCO Medical Devices and Diagnostics section on the CDSCO website: https://cdsco.gov.in/opencms/opencms/en/Medical-Device-Diagnostics/.
Intended use comes before classification
The first classification discussion should be about intended use. Without that, any class guess is weak.
A device is not classified only by how it looks. A plastic housing, tube set, patch, applicator, cassette, connector, holder, or handheld unit can fall into different regulatory paths depending on what it is meant to do.
Ask these questions before freezing design intent:
What medical purpose does the product claim?
Is it used for diagnosis, prevention, monitoring, treatment, alleviation, or support?
Is it invasive or non-invasive?
Does it contact skin, a body orifice, blood, mucosal tissue, or internal tissue?
How long does contact last?
Is it active, powered, software-controlled, or purely mechanical?
Does it deliver energy, medicine, fluid, pressure, suction, or a signal?
Is it reusable or single-use?
Will it be used by a trained professional, caregiver, patient, or technician?
Could failure cause minor discomfort, delayed diagnosis, serious harm, or life-threatening risk?
These answers shape the classification discussion. India uses Classes A, B, C and D for medical devices, not Classes I, II, III and IV. The higher the risk, the more care teams must take in design records, manufacturing controls, verification, validation, and post-market handling.
Avoid locking tooling while the intended use is still changing. A change from “general wellness accessory” to “patient monitoring accessory” can affect claims, design controls, risk files, labelling, and manufacturing records.
Classification is a manufacturing input, not only a regulatory formality
Many startups treat classification as something to check after the industrial design is complete. That creates rework.
Good manufacturing planning uses classification as an input. It helps the team decide what evidence and controls need to exist before parts are made at scale.
For example, classification discussions can influence:
Material selection and biocompatibility thinking
Part geometry and cleanability
Assembly method and access to inspection points
Traceability of moulded components
Labelling space and permanent markings
Packaging concept and transport protection
Jigs and fixtures needed for repeatable output
Controls for critical dimensions
User safety features and misuse prevention
This is where CDSCO medical device classification connects with design for manufacturing. A part that is easy to mould is not automatically ready for regulated manufacturing. The team still needs to know which surfaces are critical, which dimensions affect safety or function, and which features need inspection.
A startup may have a working prototype made through 3D printing or hand assembly. That prototype proves an idea. Tooling asks a different question: “Can the same design be made repeatedly, inspected clearly, and supported with records?”
Questions to ask before cutting moulds
Tooling is a commitment. Once mould steel is cut, changes become slower and more expensive. Before mould design begins, teams should run a classification-led manufacturing review.
What is the exact intended use statement?
Write the intended use in plain language. Avoid broad claims that the product cannot support.
A weak statement says:
“The device helps improve patient care.”
A clearer statement says what the product does, for whom, where, and under what conditions. The wording should match design, evidence, labelling, and user instructions.
If the intended use is still being debated, keep tooling on hold or restrict work to flexible prototype tooling concepts.
What claims will appear on the label and marketing material?
Claims can move the product into a different risk conversation. A device claimed for screening, diagnosis, treatment, monitoring, or life-supporting use will be viewed differently from a device used for general support.
Manufacturing teams should not treat labelling as a late-stage activity. Label size, symbol space, warnings, user instructions, lot information, and traceability details can affect part design and packaging.
Which part of the device creates the main risk?
Risk may sit in the patient-contacting component, the software logic, the measuring element, the sterile barrier, the power supply, the fluid path, or the user interface.
For moulded products, the high-risk area is often not the largest part. It may be a small connector, sealing feature, latch, dosing feature, sharp interface, or fluid-contacting channel. These need early attention in DFM and inspection planning.
Is the product active, non-active, invasive, or implantable?
These terms matter in classification discussions. An active device depends on a power source other than the body or gravity. An invasive device enters the body through a body orifice or body surface. Implantable devices remain in the body after a procedure.
Do not assume class based on product size or business category. A small component can carry major risk if its failure affects diagnosis or therapy.
How long does the device contact the body?
Contact duration can influence risk. Short-term contact is different from prolonged or long-term contact. Even external devices need careful evaluation if they contact broken skin, mucosa, blood, or sensitive patient groups.
This question also affects material selection, surface finish, cleaning assumptions, and packaging decisions.
Will it be single-use, reusable, or reprocessed?
A single-use product has different manufacturing and packaging questions from a reusable device.
For reusable devices, ask how the product will be cleaned, disinfected, or sterilised, if applicable. Ask whether the design has crevices, undercuts, rough surfaces, or material choices that make cleaning difficult. Do not assume every device needs animal or human trials. Evidence expectations depend on the device, claims, risk, and applicable standards or regulatory requirements.
Which classification rule appears relevant?
CDSCO publishes official information for medical devices and diagnostics on its website. Teams should check the applicable rules, notifications, guidance, and device lists from the official source rather than relying only on informal summaries.
Search terms such as Class A B C D, India medical devices may help teams start learning, but final decisions should be based on intended use, risk, current rules, and qualified regulatory review.
A practical pre-tooling checklist for startups
Use this checklist before moving from prototype to mould design.
Intended use statement is written and internally agreed.
User group is clear.
Use environment is clear.
Medical claims are listed and checked for consistency.
Patient contact type is identified.
Contact duration is identified.
Active or non-active status is understood.
Invasive or non-invasive status is understood.
Single-use or reusable status is defined.
Critical dimensions are marked on drawings.
Critical materials are identified.
Key risks are listed in a basic risk file.
Labelling and instructions are considered during product design.
Packaging concept is discussed.
Inspection points are visible and measurable.
Assembly method is practical for repeat production.
Jigs and fixtures needed for consistency are identified.
Mould design inputs include regulatory and manufacturing needs.
Classification has been reviewed against official CDSCO information.
Regulatory advice is taken where the classification is unclear.
This checklist is not a substitute for formal regulatory work. It helps prevent avoidable manufacturing decisions before classification is properly considered.
How classification affects DFM and mould planning
Design for manufacturing should not only reduce cycle time or simplify assembly. In medical device projects, DFM should also protect safety, repeatability, and inspection.
A classification-aware DFM review may ask:
Can the chosen material support the intended use?
Are wall thicknesses suitable for moulding without sink, warpage, or weak zones?
Are patient-contacting surfaces easy to inspect?
Are sharp edges controlled where users or patients may touch the part?
Can the part be assembled without hidden defects?
Is there space for required markings or labels?
Can the mould design support consistent critical features?
Can production jigs reduce variation in assembly or testing?
These are general best practices for medical device manufacturing. They apply whether the product is a diagnostic accessory, delivery component, housing, support device, or part of a larger system.
Medimals Healthcare, Chennai, supports medical device OEMs and startups in product design, DFM, jigs, mould design, mould making, and injection moulding. These capabilities can help teams convert design intent into manufacturable parts. Regulatory classification decisions, licensing strategy, and formal submissions should be handled with suitable regulatory expertise and reference to official CDSCO sources.
Common mistakes that create rework
Startups often move fast because funding, pilots, and customer discussions are active at the same time. Speed is useful, but some shortcuts create expensive loops.
Freezing the enclosure before defining claims
The enclosure may need warnings, markings, tamper evidence, service access, sealing features, or space for labels. If claims change later, the enclosure may need changes too.
Treating accessories as low risk by default
Accessories can influence safety or performance. A holder, connector, tube, adaptor, applicator, or cassette may affect the device’s intended medical function. Class cannot be assigned without intended use.
Ignoring manufacturing records during prototyping
Prototype teams often rely on verbal knowledge. Manufacturing needs drawings, specifications, material records, inspection plans, and change control. If these are built early, the move to production becomes cleaner.
Assuming one evidence path for all devices
Not every device needs the same type of testing. Do not assume every medical device requires animal or human trials. Evidence depends on risk, intended use, claims, applicable standards, device type, and regulatory expectations.
Copying another country’s class system
India uses Classes A, B, C and D. Do not replace them with Class I, II, III or IV from other jurisdictions. International references may be useful for understanding, but Indian classification must be checked under the Indian regulatory framework.
Where Medimals fits in the pre-tooling stage
A good manufacturing partner should ask uncomfortable questions before mould work begins. That is better than discovering gaps after samples fail inspection or after the intended use changes.
Medimals can support teams with the engineering and manufacturing side of this preparation, including:
Product design support for manufacturability
DFM review for moulded components
Jig concepts for repeatable assembly or inspection
Mould design inputs based on part function and production needs
Mould making for plastic components
Injection moulding support for planned production
These are company capabilities, not regulatory guarantees. The right workflow is collaborative. The startup or OEM defines intended use and regulatory direction with qualified advice. The manufacturing team then converts that clarity into practical design, tooling, and production decisions.
FAQs
Can we decide the CDSCO class from the product name?
No. The product name is not enough. Classification depends on intended use, claims, risk, contact type, duration of use, active or non-active nature, and other device-specific factors.
Should tooling wait until classification is fully discussed?
For most medical device projects, yes. At least the intended use, key risks, material assumptions, and likely classification route should be reviewed before hard tooling. This reduces rework in mould design, labelling, inspection, and packaging.
Does every medical device startup need clinical or animal studies?
No. Evidence needs vary by device type, risk, intended use, and claims. Some products may need specific performance, safety, usability, stability, biocompatibility, electrical, software, or other evidence. Formal advice should be taken for the specific product.
Build the manufacturing plan around the intended use
Before tooling, ask the classification questions that shape the product. Define the intended use, check the likely risk class under India’s Class A to D framework, and make sure design, DFM, mould planning, and inspection all support that direction.
If you are preparing a medical device component or product for tooling, speak with Medimals Healthcare about product design, DFM, mould design, mould making, jigs, and injection moulding support.
The best time to catch a classification-led design issue is before the mould is cut.
Comments